Epidemiology of chronic myeloid leukaemia (CML)
Authors:
- Joerg HasfordJHJoerg Hasford
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 22 (3) , 295-302
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in GermanyLeukemia, 2008
- Kinetic of chronic myeloid leukaemia (CML) prevalence in Northern France since the introduction of imatinibJournal of Clinical Oncology, 2008
- Incidence, Comorbidity and Treatment Survey of Chronic Myeoloid Leukemia in Germany.Blood, 2007
- Chronic myeloid leukaemiaThe Lancet, 2007
- The evolution of the population-based cancer registryNature Reviews Cancer, 2006
- The Scotland Leukaemia Registry Audit of Incidence, Diagnosis and Clinical Management of New Patients with Chronic Myeloid Leukaemia in 1999 and 2000Scottish Medical Journal, 2004
- European health systems and cancer careAnnals of Oncology, 2003
- Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983–1992European Journal of Haematology, 2000
- Age and sex distributions of hematological malignancies in the U.K.Hematological Oncology, 1997
- UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic responseThe Lancet, 1995